Influence of Atazanavir Treatment on Endothelial Dysfunction, Vascular Inflammation and Heme Oxygenase Activity in Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Atazanavir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2010 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.